Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer

Fluoropyrimidine-based chemotherapy (CT) has been the mainstay of care of metastatic colorectal cancer (mCRC) for years. Response rates are only observed, however, in about half of treated patients, and there are no reliable tools to prospectively identify patients more likely to benefit from therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Estevez-Garcia, Purificacion, Rivera, Fernando, Molina-Pinelo, Sonia, Benavent, Marta, Gómez, Javier, Limón, Maria Luisa, Pastor, Maria Dolores, Martinez-Perez, Julia, Paz-Ares, Luis, Carnero, Amancio, Garcia-Carbonero, Rocio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467428/
https://www.ncbi.nlm.nih.gov/pubmed/25730906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467428/
https://www.ncbi.nlm.nih.gov/pubmed/25730906

Ejemplares similares